Concepedia

Eduard R. Shmalenyuk

ER

3

Publications

105

Citations

3

H-Index

2013

Active since

Affiliations

Engelhardt Institute of Molecular Biology(Current)

Eduard R. Shmalenyuk is an author at Engelhardt Institute of Molecular Biology specializing in drug discovery, medicine, and tuberculosis.

Top concepts

MedicinePharmacologyTuberculosisDrug DiscoveryBiochemistryDrug ResistanceMicrobiologyNatural SciencesBioorganic ChemistryAntimicrobial Resistance

Publications per year

2013–2015

3

Publications

3

Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides

Eduard R. Shmalenyuk, Inna L. Karpenko, Sergey N. Kochetkov et al. · Bioorganic & Medicinal Chemistry · 2013 · 48 citations

Pulmonary Tuberculosis, Mdr Ms-115, Medicine +11

Synthesis and evaluation of C-5 modified 2′-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase

Liudmila A. Alexandrova, Vladimir O. Chekhov, Eduard R. Shmalenyuk et al. · Bioorganic & Medicinal Chemistry · 2015 · 30 citations · Full text

Biochemistry, Medicine, Tuberculosis +6

Novel inhibitors of<i>Mycobacterium tuberculosis</i>growth based on modified pyrimidine nucleosides and their analogues

Eduard R. Shmalenyuk, Sergey N. Kochetkov, Liudmila A. Alexandrova · Russian Chemical Reviews · 2013 · 27 citations

Bioorganic Chemistry, Modified Pyrimidine Nucleosides, Pyrimidine Nucleoside Derivatives +16

Rows per page

1–3 of 3